Clinical Trial

Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias

Study acronym: SMASH 1
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify markers of increased risk for incident ventricular arrhythmias and cardiovascular events in patients already being treated with an implantable cardioverter-defibrillator (ICD) by exploring patient history and clinical findings, biological markers, ECG markers, and echocardiographic markers.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2016-08-11; most recent amendment 2020-06-02.
Status change: Recruiting → Active, Not Recruiting 2020-06-02
Status change: Not Yet Recruiting → Recruiting 2016-08-12
Trial Details
NCT Number NCT02864771
Lead Sponsor University Hospital, Akershus
Collaborators: Helse Stavanger HF, University of Oslo
Conditions Ventricular Arrhythmias, Implantable Defibrillator User, Biological Markers, Heart Disease
Enrollment 504 participants
Start Date 2016-08
Primary Completion 2019-12-31 (estimated)
Study Completion 2050-12 (estimated)
Updated on ClinicalTrials.gov 2020-06-04